Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value
$3.76B
Total Bought
$1.85B
Total Sold
$1.96B
Net Transaction
-$112.37M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
REVOLUTION MEDICINES INC(RVMD)2,211,01810,629,822+8,418,804204,9832,047,51654.45%+1,842,533
ROIVANT SCIENCES LTD(ROIV)6,797,3006,747,300-50,000179,517234,3346.23%+54,817
BELITE BIO INC(BLTE)3,057,4123,077,219+19,807456,105456,58812.14%+484
DIANTHUS THERAPEUTICS INC(DNTH)17,3570-17,3571,4570—-1,457
ABIVAX SA(ABVX)3,468,6573,621,583+152,926352,069348,2159.26%-3,853
INSMED INC(INSM)16,805,1846,431,163-10,374,0212,576,571673,60017.91%-1,902,971
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q2 2026 | TickerTrail